Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
Infused with the master antioxidantglutathionethis product efficiently detoxifies your body, supports a healthy immune system, and promotes bright, glowing skin
5.3.4 Antioxidants Various antioxidants including ascorbic acid and zinc have been frequently administered through the topical or oral routes for melasma management (Sarkar et al., 2012b
References: Hira T, Trakooncharoenvit A, Taguchi H, Hara H
US$ 21.50
US$ 24.02
US$ 20.77
